Target Sufficiency® enables direct, quantitative analysis of drug target systems in cells, tissues, and tissue models, including formalin-fixed, paraffin-embedded (FFPE) tissues. Drug targets can be measured in their diverse forms (including sequence or splice variants and post-translationally modified forms) together with their key protein co-regulators that constitute therapeutic target systems. Target Sufficiency® defines the target system in its native cell or tissue environment and enables development of more effective therapeutic strategies and personalized therapies.
Complete the form to receive an overview of Target Sufficiency®, a high-resolution mass-spec platform optimized for the quantification of proteins downstream of RNA and gene editing therapies.
Target Sufficiency® for the Quantification of Proteins Downstream of RNA and Gene Editing Therapeutics
Quantify drug target proteins with ultra-precision from any sample type.
Discovery and Translational Sciences Target sufficiency
